2072 related articles for article (PubMed ID: 32183948)
1. m
Huang H; Weng H; Chen J
Cancer Cell; 2020 Mar; 37(3):270-288. PubMed ID: 32183948
[TBL] [Abstract][Full Text] [Related]
2. Interaction between N
Chen Y; Lin Y; Shu Y; He J; Gao W
Mol Cancer; 2020 May; 19(1):94. PubMed ID: 32443966
[TBL] [Abstract][Full Text] [Related]
3. Novel insights into the interplay between m
Yi YC; Chen XY; Zhang J; Zhu JS
Mol Cancer; 2020 Aug; 19(1):121. PubMed ID: 32767982
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive analyses of m6A regulators and interactive coding and non-coding RNAs across 32 cancer types.
Shen S; Zhang R; Jiang Y; Li Y; Lin L; Liu Z; Zhao Y; Shen H; Hu Z; Wei Y; Chen F
Mol Cancer; 2021 Apr; 20(1):67. PubMed ID: 33849552
[TBL] [Abstract][Full Text] [Related]
5. N
Xiong X; Li X; Yi C
Curr Opin Chem Biol; 2018 Aug; 45():179-186. PubMed ID: 30007213
[TBL] [Abstract][Full Text] [Related]
6. N6-methyladenosine RNA modification and its interaction with regulatory non-coding RNAs in colorectal cancer.
Ge Y; Liu T; Wang C; Zhang Y; Xu S; Ren Y; Feng Y; Yin L; Pu Y; Liang G
RNA Biol; 2021 Nov; 18(sup2):551-561. PubMed ID: 34674600
[TBL] [Abstract][Full Text] [Related]
7. Novel Insights Into the Role of N6-Methyladenosine RNA Modification in Bone Pathophysiology.
Chen J; Tian Y; Zhang Q; Ren D; Zhang Q; Yan X; Wang L; He Z; Zhang W; Zhang T; Yuan X
Stem Cells Dev; 2021 Jan; 30(1):17-28. PubMed ID: 33231507
[TBL] [Abstract][Full Text] [Related]
8. Surmounting cancer drug resistance: New insights from the perspective of N
Li B; Jiang J; Assaraf YG; Xiao H; Chen ZS; Huang C
Drug Resist Updat; 2020 Dec; 53():100720. PubMed ID: 32892147
[TBL] [Abstract][Full Text] [Related]
9. N
Quan C; Belaydi O; Hu J; Li H; Yu A; Liu P; Yi Z; Qiu D; Ren W; Ma H; Gong G; Ou Z; Chen M; Sun Y; Chen J; Zu X
Front Immunol; 2021; 12():697026. PubMed ID: 34526985
[TBL] [Abstract][Full Text] [Related]
10. Roles and implications of mRNA N
Zeng L; Huang X; Zhang J; Lin D; Zheng J
Cancer Commun (Lond); 2023 Jul; 43(7):729-748. PubMed ID: 37350762
[TBL] [Abstract][Full Text] [Related]
11. N6-methyladenosine RNA modifications: a potential therapeutic target for AML.
Hu R; Liao P; Xu B; Qiu Y; Zhang H; Li Y
Ann Hematol; 2023 Aug; ():. PubMed ID: 37548690
[TBL] [Abstract][Full Text] [Related]
12. N6-methyladenosine methyltransferases: functions, regulation, and clinical potential.
Huang W; Chen TQ; Fang K; Zeng ZC; Ye H; Chen YQ
J Hematol Oncol; 2021 Jul; 14(1):117. PubMed ID: 34315512
[TBL] [Abstract][Full Text] [Related]
13. The dual role of N6-methyladenosine modification of RNAs is involved in human cancers.
He L; Li J; Wang X; Ying Y; Xie H; Yan H; Zheng X; Xie L
J Cell Mol Med; 2018 Oct; 22(10):4630-4639. PubMed ID: 30039919
[TBL] [Abstract][Full Text] [Related]
14. The role of m
Chen XY; Zhang J; Zhu JS
Mol Cancer; 2019 May; 18(1):103. PubMed ID: 31142332
[TBL] [Abstract][Full Text] [Related]
15. Environmental exposures and RNA N6-Methyladenosine modified long Non-Coding RNAs.
Cayir A
Crit Rev Toxicol; 2020 Sep; 50(8):641-649. PubMed ID: 32924714
[TBL] [Abstract][Full Text] [Related]
16. N
Weng H; Huang H; Chen J
Adv Exp Med Biol; 2023; 1442():105-123. PubMed ID: 38228961
[TBL] [Abstract][Full Text] [Related]
17. [Progress in epigenetic modification of mRNA and the function of m6A modification].
Gan H; Hong L; Yang F; Liu D; Jin L; Zheng Q
Sheng Wu Gong Cheng Xue Bao; 2019 May; 35(5):775-783. PubMed ID: 31222996
[TBL] [Abstract][Full Text] [Related]
18. Reading, writing and erasing mRNA methylation.
Zaccara S; Ries RJ; Jaffrey SR
Nat Rev Mol Cell Biol; 2019 Oct; 20(10):608-624. PubMed ID: 31520073
[TBL] [Abstract][Full Text] [Related]
19. The m
Uddin MB; Wang Z; Yang C
Mol Cancer; 2021 Apr; 20(1):61. PubMed ID: 33814008
[TBL] [Abstract][Full Text] [Related]
20. Novel insights into m
Jia J; Wu S; Jia Z; Wang C; Ju C; Sheng J; He F; Zhou M; He J
Int J Biol Sci; 2022; 18(11):4432-4451. PubMed ID: 35864970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
